Hein Jan VerberneFollowAmsterdam University Medical Centers1 paperORCID 0000-0003-3774-2414OpenAlexPapersEuropean Heart JournalHuman trial·29 SepPotential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetesGLP-1 receptor agonists
European Heart JournalHuman trial·29 SepPotential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetesGLP-1 receptor agonists